Elevated levels of GLI1 (glioma-associated oncogene homolog 1) protein in human breast cancer are associated with unfavorable prognosis and progressive stages of disease. ...
... first identified stem cells in human breast cancer in 2003.
In the current study, researchers ... inhibitors of these pathways that might be effective in targeting cancer stem cells in women whose tumors ...
... exposure of estrogen. ACI rats, like humans, develop mammary tumors after exposure to estrogen ... several key features with the majority of human breast cancers, particularly in how tumors start. Because ...
... allows for selective depletion of cellular proteins.
Interestingly, they found the same results in the human breast cancers that they found in mice. In fact, 60 percent of 67 tumors analyzed showed a ...
... first to show that cyclin d1 is required for breast cancer growth in mice. As cyclin d1 ... process. As Notch signaling is activated in human breast cancer, (and a negative regulator of Notch signaling ...
... relevant markers of a large subgroup of human breast cancer and find a novel therapeutic target ... resistant to chemotherapy and do not express mature breast markers like estrogen receptor. These features ...
... If you're obese, and at high risk for breast cancer, diet and exercise could help prevent tumor ... signaling pathways proven to be altered in human breast cancers, following either caloric restriction or ...
... ball" was akin to the process, in living creatures, by which a breast epithelial tumor would form.
To test ... e., present in abnormal quantity, in human breast cancer. Myc is known to activate pathways ...
... associated combined exposure to progestin and estrogen with an increased incidence of human breast cancer in this population," said Hyder, who is also the Zalk Endowed Professor of Tumor Angiogenesis ...
Recent studies suggest that human breast cancer risk is increased by outside exposure to the hormone progestin, ... PRIMA-1, a small molecule drug that targets the most common mutated gene, p53, in human ...
Recent studies suggest that human breast cancer risk is increased by outside exposure to the hormone progestin, ... PRIMA-1, a small molecule drug that targets the most common mutated gene, p53, in human ...
... finding that apple phytochemicals inhibit an important inflammation pathway (NFkB) in human breast cancer cells.
Breast cancer is the most frequently diagnosed invasive cancer and the second leading ...
... lipocalin 2, and found that cell migration was significantly inhibited. When they transplanted human breast cancer cells into animals, those from tumors making lipocalin 2 were more locally invasive ...
... About 40,000 women die of metastatic breast cancer every year.
"Currently, anyone with ... and Robinson developed a triple immunostain for human breast cancer samples that simultaneously labels the three ...
... meeting of the American Association for Cancer Research. Human breast cancer grafts in mice dropped ... showed that PEA-15 stymied ovarian cancer in lab experiments, and that high expression of the protein ...
